4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0001193125-26-144086
CEO sold 30,078 shares at $24.58 ($739,317)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Evans John M. CEO | 2026-04-01 | Sale 10b5-1 | −30,078 | $24.58 | $739,317 | 1,047,205 | D: show line 1 in the form |
| Open-market sales · 30,078 sh · avg $24.58 · $739,317 | |||||||
Loading xslF345X06/ownership.xml…